Julie McHugh
CIK 1487179 · Chief Operating Officer · last filed 2026-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.04M
Companies
8
Total Filings
86
Lifetime Open-Market Net
-$2.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRWD | Director | 250,749 | $3.80 | $952.8K | -$827.2K | 26 | 2026-06-17 |
| LNTH | Director | 30,099 | $102.64 | $3.09M | -$1.34M | 22 | 2026-05-18 |
| Evelo Biosciences, Inc. (EVLO) Delisted | Director | — | $0.00 | — | $0 | 3 | 2023-06-12 |
| AERIE PHARMACEUTICALS INC (AERI) Delisted | Director | 0 | $15.25 | $0 | $0 | 9 | 2022-11-21 |
| TREVENA INC (TRVN) Delisted | Director | — | $0.01 | — | $0 | 7 | 2020-05-15 |
| EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Director | — | — | — | $0 | 2 | 2015-06-08 |
| VIROPHARMA INC (VPHM) Delisted | Director | 8,666 | — | — | $0 | 5 | 2014-01-03 |
| ENDO HEALTH SOLUTIONS INC. (ENDP) Delisted | Chief Operating Officer | 48,046 | $0.29 | $14.1K | $0 | 7 | 2013-03-15 |
Recent Filings · Page 2 of 9
86 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-30 | LNTH | Sell (S) | −2,500 | -$196.2K | EDGAR |
| 2024-05-28 | LNTH | Notice (144) | −2,500 | -$196.2K | EDGAR |
| 2024-05-13 | LNTH | Grant (A) | +2,635 | $0 | EDGAR |
| 2023-06-22 | IRWD | Grant (A) | +22,350 | $0 | EDGAR |
| 2023-06-12 | Evelo Biosciences, Inc. (EVLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-15 | LNTH | Grant (A) | +2,012 | $0 | EDGAR |
| 2022-11-21 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Disp (D) | −16,095 | -$245.4K | EDGAR |
| 2022-09-08 | LNTH | Sell (S) | −4,300 | -$337.6K | EDGAR |
| 2022-06-13 | Evelo Biosciences, Inc. (EVLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Grant (A) | +6,245 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.